A product containing 500 mg Opium per 100 mL or 100 grams, with one or more active non narcotic ingredients in recognized therapeutic amounts, is scheduled as:

A product containing 500 mg Opium per 100 mL or 100 grams, with one or more active non narcotic ingredients in recognized therapeutic amounts, is scheduled as:

• A. Schedule III
• B. Schedule II
• C. Schedule IV
• D. Schedule I

Answer: (A)

The key idea is that opium-containing medicines are scheduled not only by how much narcotic is present, but also by whether non-narcotic active ingredients are included in therapeutic amounts. When a preparation combines opium with other active non-narcotic ingredients in recognized therapeutic amounts, the potential for abuse is considered lower, so the product falls into a less restrictive schedule than a pure opium preparation. In this case, a product with 500 mg of opium per 100 mL or 100 g, and with one or more non-narcotic active ingredients in recognized therapeutic amounts, is placed in Schedule III. If the formulation lacked any non-narcotic ingredients, it would be treated as more tightly controlled (Schedule II). Conversely, lower-narcotic-content formulations or those with different ingredient profiles could be placed in a lower schedule, but the described combination specifically corresponds to Schedule III.

The key idea is that opium-containing medicines are scheduled not only by how much narcotic is present, but also by whether non-narcotic active ingredients are included in therapeutic amounts. When a preparation combines opium with other active non-narcotic ingredients in recognized therapeutic amounts, the potential for abuse is considered lower, so the product falls into a less restrictive schedule than a pure opium preparation.

In this case, a product with 500 mg of opium per 100 mL or 100 g, and with one or more non-narcotic active ingredients in recognized therapeutic amounts, is placed in Schedule III. If the formulation lacked any non-narcotic ingredients, it would be treated as more tightly controlled (Schedule II). Conversely, lower-narcotic-content formulations or those with different ingredient profiles could be placed in a lower schedule, but the described combination specifically corresponds to Schedule III.